Glen­mark launches hair loss so­lu­tion in Rus­sia

BioSpectrum (India) - - COMPANY NEWS -

Mumbai head­quar­tered Glen­mark Phar­ma­ceu­ti­cals re­cently an­nounced the launch of Nourkrin in Rus­sia. Nourkrin is a glob­ally renowned, clin­i­cally-proven pro­teo­gly­can re­place­ment for­mula, for ad­dress­ing one of the key un­der­ly­ing causes of hair loss in males and fe­males. Nourkrin Woman and Nourkrin Man will be ex­clu­sively mar­keted in Rus­sia by Glen­mark Im­pex LLC, the Rus­sian sub­sidiary of Glen­mark Phar­ma­ceu­ti­cals Ltd., un­der a li­cens­ing agree­ment with Den­mark head­quar­tered firm Pharma Medico ApS. Glen­mark had al­ready launched Nourkrin Woman in In­dia in early 2018. Nourkrin con­tains Mar­ilex, a unique and pro­pri­etary sci­en­tific for­mula, rich in spe­cific pro­teo­gly­cans es­sen­tial for hair fol­li­cle growth. Nourkrin is a proven for­mula based on more than 56 sci­en­tific stud­ies and is rec­og­nized by lead­ing reg­u­la­tory agen­cies glob­ally.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.